InfuSystems HoldingsINFU +0.77%88 Net Margin % is 3.02% as of Mar. 2026, which is 190% above its 10-year median of 1.04. GuruFocus rates INFU with a GF Score™ of 88/100 and a GF Value™ of $9.44 (Fairly Valued). The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, InfuSystems Holdings ranks better than 60.47% on this metric.
The historical rank and industry rank for InfuSystems Holdings's Net Margin % or its related term are showing as below:
INFU'
s Net Margin % Range Over the Past 10 Years
Min: -29.13 Med: 1.04 Max: 17.8
Current: 5.56
INFU's Net Margin % is ranked better than 60.47% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs INFU: 5.56
InfuSystems Holdings (AMEX:INFU) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
InfuSystems Holdings Net Margin % Related Terms
InfuSystems Holdings Net Margin % Historical Data
* Premium members only.
The historical data trend for InfuSystems Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INFU vs TANAF, INGN, LUCD: Net Margin % Comparison
For the Medical Devices subindustry, InfuSystems Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InfuSystems Holdings (INFU) has a Net Margin % of 3.02% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on InfuSystems Holdings and its competitors. This is 190% above median its historical median of 1.04. According to the industry distribution chart, InfuSystems Holdings ranks #323 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 39.5%.
Is InfuSystems Holdings' Net Margin % too high?
InfuSystems Holdings' current Net Margin % of 3.02% is 190% above median its 10-year median of 1.04. The Medical Devices & Instruments industry median Net Margin % is 2.07. InfuSystems Holdings' value of 3.02% is 45.9% above this industry median. Based on the distribution chart, InfuSystems Holdings ranks #323 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, InfuSystems Holdings has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' Net Margin % compare to TANAF and INGN?
According to the Medical Devices & Instruments industry distribution chart, InfuSystems Holdings ranks #323 out of 817 companies for Net Margin %. This puts InfuSystems Holdings in the upper half of its industry. The industry median Net Margin % is 2.07. InfuSystems Holdings' value of 3.02% is 45.9% above this benchmark. While the company's 10-year median is 1.04 vs. the industry median of 2.07, InfuSystems Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current Net Margin % of 3.02% is 45.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on InfuSystems Holdings and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current Net Margin % is 3.02%, which is 190% above median its own 10-year median of 1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Fairly Valued. The stock's GF Value™ is $9.44, compared to a current price of $9.15 — trading 3.1% below its estimated fair value. The current Net Margin % is 3.02%, which is 190% above median its 10-year median of 1.04 and 45.9% above the Medical Devices & Instruments industry median of 2.07. InfuSystems Holdings' overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current Net Margin % is 3.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InfuSystems Holdings (INFU) Overvalued in 2026?
Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be undervalued.
The current stock price of $9.15 is trading 3.1% below its estimated GF Value™ of $9.44.
GuruFocus considers InfuSystems Holdings to be Fairly Valued.
Key valuation signals for INFU:
Net Margin %: 3.02% (190% above median its 10-year median of 1.04)
GF Value™: $9.44 vs. price of $9.15 (3.1% below fair value)
Industry Position: 45.9% above the Medical Devices & Instruments median (#323 of 817)
No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
88GF Score
Get the complete analysis for INFU
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INFU has been successfully added to your 
